The Fellow on Call: The Heme/Onc Podcast

Rouleaux University Medical Center
  • 4,9 (137)
  • МЕДИЦИНА
  • ДВАЖДЫ В НЕДЕЛЮ
The Fellow on Call: The Heme/Onc Podcast

We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.

  1. Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease

    8 ЯНВ.

    Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease

    This week, we round out our AML series with a detailed discussion about the approach to management of relapsed and refractory disease. This has been a VERY long road going through all management of AML. We hope that you have continued to build on our discussions week-to-week. An exciting treatment paradigm that is ever-evolving! Episode contents: - How do we define primary induction failure in AML? - What are options for treatment of refractory disease? What is the mechanism of action of these treatment options? - What are options for relapsed disease? - What targeted therapies are available for relapsed AML? ****This episode is sponsored by our global research partners! Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

  2. Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy

    18.12.2024

    Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy

    In today’s episode, we discuss how to approach AML treatment for patients who are unfit for intensive therapy. Episode contents: - How do we assess fitness for intensive AML? - What are options for patients who are unfit for intensive chemotherapy for AML? - What are important genetic mutations are important to check for? - What are the key trials that inform our management in this space? - How do we dose venetoclax? - How do we sequence the available agents? ****Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

  3. Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML

    11.12.2024

    Episode 124: AML Series, Pt 10 - Allogeneic transplant for AML

    In today’s episode, we welcome back Dr. Amar Kelkar for part 2 of our two-part discussion on allogeneic transplant. In this episode, we build on our prior discussion regarding transplant, this time focusing on transplant for the treatment of AML. Episode contents: - What are the different conditioning regimens available? - How do we decide which regimen is optimal for our patients? - What is the role of MRD testing? - What is the role of maintenance therapy post-transplant? - What are treatment options for GVHD? - A discussion on racial disparities in transplant ****Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

  4. Episode 123: AML Series, Pt 9 - Introduction to Allogeneic Transplant

    04.12.2024

    Episode 123: AML Series, Pt 9 - Introduction to Allogeneic Transplant

    In today’s episode, we welcome back Dr. Amar Kelkar for part 1 of our two-part discussion on allogeneic transplant. In this episode, we discuss the fundamental approach to patient selection and stem cell source selection. As you all know from this series, allogeneic transplants play a pivotal role in the management of AML. Dr. Kelkar’s pearls of wisdom help make this confusing topic so much more approachable! Episode contents: - What factors do we incorporate when considering a patient for allogeneic transplant? - How do we use HLA-matching? - What are the pros and cons of the different sources of stem cells? ****Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

  5. Episode 122: AML Series, Pt 8 - AML Maintenance Therapies

    13.11.2024

    Episode 122: AML Series, Pt 8 - AML Maintenance Therapies

    This week, we continue our series focusing on acute myeloid leukemia. In this episode, we talk about maintenance therapies in AML. Episode contents: - A recap of cytarabine consolidation - Why do we do maintenance therapy? - What are hypomethylating agents and how do they work? - Important targeted agents that play a role in maintenance therapy ****This episode is sponsored by our Global Research Partners! Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

  6. Episode 121: AML Series, Pt 7 - AML Consolidation: Role of Allogeneic Transplant

    06.11.2024

    Episode 121: AML Series, Pt 7 - AML Consolidation: Role of Allogeneic Transplant

    This week, we continue our discussion on consolidation and maintenance therapies for AML, this time highlighting the role of allogeneic stem cell transplants. This episode builds on our prior episode, so if you have not listened to this just yet, we highly recommend doing so! Episode contents: - A recap on approach to AML consolidation - The role of allogeneic transplants - The role of MRD testing in AML management ****Have some time and want to make some extra money? Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

  7. Episode 120: AML Series, Pt 6 - AML Consolidation: Therapeutic Approaches

    30.10.2024

    Episode 120: AML Series, Pt 6 - AML Consolidation: Therapeutic Approaches

    This week, we move to our next phases of therapy for AML, which are consolidation and maintenance. Be sure to check out our prior episodes for a discussion on initial workup and how we incorporate recurrent genetic abnormalities into how we think about AML. Check out figure 1 from this paper for a helpful diagram! Episode contents: - A recap on approach to AML treatment - Who do we consider for allogeneic transplant? - What are common therapy-related AML cytogenetic abnormalities to be aware of? - How do we approach consolidation? Role of G-CSF? ****Have some time and want to make some extra money? Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

  8. Episode 119: AML Series, Pt 5 - AML Induction: Options for Upfront Therapy

    16.10.2024

    Episode 119: AML Series, Pt 5 - AML Induction: Options for Upfront Therapy

    This week, we round out our discussion regarding AML induction, this time focusing on the treatment options in the first line setting. We go through the various options, the dosing strategies, and the data behind them. Be sure to check out parts one and two of this three-part induction discussion, as we continue to build on these concepts! Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this conversation! Episode contents: - What are our options for upfront induction therapy? - How do we select patients for the "add-ons" to induction therapy? - What is the data behind these options? ****This episode is sponsored by our Global Research Partners! Have some time and want to make some extra money? Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

См. все (134)

4,9
из 5
Оценок: 137

Об этом подкасте

We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.

Информация

  • Автор
    Rouleaux University Medical Center
  • Годы выхода
    2022 - 2025
  • Выпуски
    134
  • Ограничения
    Без ненормативной лексики
  • Сайт подкаста
    The Fellow on Call: The Heme/Onc Podcast

Вам может также понравиться

Чтобы прослушивать выпуски с ненормативным контентом, войдите в систему.

Следите за новостями подкаста

Войдите в систему или зарегистрируйтесь, чтобы следить за подкастами, сохранять выпуски и получать последние обновления.
Выберите страну или регион

Африка, Ближний Восток и Индия

Азиатско-Тихоокеанский регион

Европа

Латинская Америка и страны Карибского бассейна

США и Канада